Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0.470. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Breast Cancer Research Foundation
Grant: IIDRP-16-001
U.S. Department of Veterans Affairs
Grant: 5101BX000196-04
U.S. Department of Veterans Affairs
Grant: Senior Research Career Scientist Award
National Institutes of Health
Grant: CA116021
National Institutes of Health
Grant: CA116021-S1
National Institutes of Health
Grant: CA34590
National Institutes of Health
Grant: P30CA142543
National Institutes of Health
Grant: P30CA68485
National Institutes of Health
Grant: P50CA098131
National Institutes of Health
Grant: R37CA233770
Cancer Prevention and Research Institute of Texas
Grant: RR190020
U.S. Department of Defense
Grant: W81XWH2210019
University of Texas Southwestern Medical Center
Grant: Disease Oriented Clinical Scholar Award
NCI NIH HHS
Grant: R01 CA116021
NCI NIH HHS
Grant: P30 CA068485
BLRD VA
Grant: I01 BX000196
NCI NIH HHS
Grant: R01 CA034590
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R37CA233770-04
Combining senescence-inducing and senolytic agents to improve melanoma therapy
National Institutes of Health
Grant: 5R01CA116021-09
Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma
National Institutes of Health
Grant: 3P50CA098131-15S1
SPORE in Breast Cancer
National Institutes of Health
Grant: 5R01CA034590-29
Chemokine Receptor Studies: Defining the Dynamics of the Chemosynapse
National Institutes of Health
Grant: 3P30CA142543-12S1
Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)
FWCI
3.62
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing
Additional file 1 of Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing